Decoy nanoparticles could provide a quick, effective treatment for COVID-19

They might look like cells and act like cells. But a new potential COVID-19 treatment is actually a cleverly disguised trickster, which attracts viruses and binds them, rendering them inactive. As the ever-evolving SARS-CoV-2 virus begins to evade once promising treatments, such as monoclonal antibody therapies, researchers have become more interested in these "decoy" nanoparticles. Mimicking regular cells, decoy nanoparticles […]

Continue reading »

COVID-19 hasn’t caused kids to become mentally ill, but it has unmasked symptoms, psychiatrist says

The coronavirus pandemic has caused feelings of anxiety and unhappiness for youth across the country, but it hasn’t caused new mental illness, according to Northwestern University experts. The Centers for Disease Control and Prevention’s (CDC) recent survey findings showed a stark decline in teen mental health, including increased feelings of hopelessness and thoughts of suicide, with a particular impact on […]

Continue reading »

VectorBuilder to expand with $500 million ‘Gene Delivery Research and Manufacturing Campus

VectorBuilder Inc. – a global leader in gene delivery solutions – has announced the construction of a new R&D and manufacturing center in Guangzhou, China. The ‘Gene Delivery Research and Manufacturing Campus’ will significantly expand VectorBuilder’s R&D capabilities and its production capacity for both research-use and cGMP-grade gene delivery vectors, allowing the company to continue supporting groundbreaking research worldwide. The […]

Continue reading »

What do we know about ‘stealth omicron’ so far?

What do we know about “stealth omicron” so far? It’s an extra-contagious version of the omicron variant, but it doesn’t seem to cause more severe disease. Since it was first identified in November, BA.2 has been spreading around the globe, driving new surges in parts of Asia and Europe. It’s now the dominant coronavirus version in the U.S. and more […]

Continue reading »

New study identifies molecular features tied to breast cancer tumor spread

Susana Garcia-Recio, Ph.D., a research associate in the lab of Charles M. Perou, Ph.D., at UNC Lineberger Comprehensive Cancer Center, will present findings that identified molecular features responsible for the development and progression of metastatic breast cancer at the 2022 American Association for Cancer Research annual meeting. Focused on understanding the difference in the microenvironments that surround cancer cells in […]

Continue reading »

Researchers make progress to develop a drug for treating metabolic syndrome

Metabolic syndrome increases a person's risk for diabetes, heart disease, and stroke, and includes conditions such as obesity, high blood pressure and high blood sugar. In a recent mouse-model study, published in Cell Metabolism, researchers at University Hospitals (UH), Harrington Discovery Institute at UH, and Case Western Reserve University have furthered their progress to develop a drug to treat metabolic […]

Continue reading »
1 486 487 488 489 490 1,322